BioTelemetry, Inc. announced the Company is party to an Agreement and Plan of Merger, dated as of December 18, 2020 (the Merger Agreement), with Philips Holding USA Inc., (Parent), and Davies Merger Sub, Inc., and a wholly owned subsidiary of Parent (Purchaser). On February 9, 2021, pursuant to the terms of the Merger Agreement, Purchaser merged with and into the Company, with the Company continuing as the surviving corporation (the Merger). Upon completion of the Merger, the Company became a wholly owned subsidiary of Parent. In connection with the Merger, each of Kirk Gorman, Joseph H. Capper, Anthony J. Conti, Laura Dietch, Joseph A. Frick, Colin Hill, Tiffany Olson, Stephan Rietiker, M.D., Rebecca W. Rimel, and Robert J. Rubin, M.D. resigned as directors of the Company's Board of Directors and from all committees of the Board on which such directors served, effective as of the effective time of the Merger (the Effective Time). In accordance with the terms of the Merger Agreement, the directors of Purchaser immediately prior to the Effective Time, which consisted of Ling Liu and Joseph E. Innamorati, became the directors of the Company immediately after the Effective Time.